Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ATPase
    (3)
  • Apoptosis
    (3)
  • Autophagy
    (2)
  • Endogenous Metabolite
    (2)
  • Adrenergic Receptor
    (1)
  • Antifungal
    (1)
  • Interleukin
    (1)
  • Mitochondrial Metabolism
    (1)
  • ROS
    (1)
  • Others
    (4)
TargetMol | Tags By Natures
  • Cymbopogon
    (1)
  • Microcos
    (1)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (4)
  • Cancer
    (2)
  • Inflammation
    (2)
  • Immune System
    (1)
  • Infection
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

ouabain

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    5
    TargetMol | Natural_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • Oligonucleotides
    1
    TargetMol | All_Pathways
  • Ouabain octahydrate
    G-Strophanthin, Acocantherine
    T131811018-89-6
    Ouabain octahydrate (Acocantherine) is a cardiac glycoside that inhibits Na(+)/K(+) ATPase. Ouabain octahydrate regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1.
    • $37
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Rostafuroxin
    PST 2238
    T2621156722-18-8
    Rostafuroxin (PST 2238) has been used in trials studying the treatment of Essential Hypertension.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Ouabain hydrate
    Ouabain (hydrate), g-Strophanthin, g Strophanthin
    T202100340169-01-9
    Ouabain is a cardiac steroid that binds to and inhibits the activity of Na(+), K(+)-ATPase. This compound enhances myocardial contractility, stabilizes heart rate, and promotes the growth of cardiac, vascular, and neural cells both in vitro and in vivo.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Anhydro-Ouabain
    T2091603029806-33-2
    Anhydro-Ouabain (compound 20) is a cardiotonic steroid with anti-inflammatory and neuroprotective properties, making it useful for neurological research.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Arachidonic acid
    Vevodar, Immunocytophyte, Immunocytophyt, arachidonate
    T4129506-32-1
    Arachidonic acid (Immunocytophyt) is a polyunsaturated omega-6 essential fatty acid that serves as a major component of biological membranes and animal phospholipids. It is synthesized from dietary linoleic acid and acts as a precursor to lipid mediators such as prostaglandins, thromboxanes, and leukotrienes. Arachidonic acid can improve cognitive responses and cardiovascular function and is commonly used to induce paw edema models.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Nerol
    Neryl alcohol, Cis-Geraniol
    T5645106-25-2
    Nerol (Neryl alcohol) is a monoterpene found in many essential oils, such as lemon balm and hop.Nerol can lessened the severity of ouabain-triggered arrhythmias in mammalian heart.
    • $36
    In Stock
    Size
    QTY
  • Cinobufagin
    Cinobufagine
    T3432470-37-1
    Cinobufagin (Cinobufagine) is a selective Na+/K+-ATPase inhibitor. The activity of Cinobufagin is same as ouabain.
    • $44
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Transdermal Peptide (TD 1 (peptide))
    T37766918629-48-8
    Transdermal Peptide is a 11-amino acid peptide, binds to Na+/K+-ATPase beta-subunit (ATP1B1), and enhances the transdermal delivery of many macromolecules. Transdermal Peptide (TD1) binds to ATP1B1, and mainly interacts with the C-terminus of ATP1B1 in yeast and mammalian cells. The interaction affects the expression and localization of ATP1B1 and epidermal structure, but can be antagonized by the exogenous competitor ATP1B1 or be inhibited by ouabain. Inhibition of Transdermal Peptide binding to ATP1B1 causes decreased delivery of macromolecular drugs across the skin[1]. [1]. Wang C, et al. Role of the Na(+)/K(+)-ATPase beta-subunit in peptide-mediated transdermal drug delivery. Mol Pharm. 2015 Apr 6;12(4):1259-67.
    • $70
    Inquiry
    Size
    QTY
  • Riboxin
    IDP
    T8127586-04-4
    Riboxin (IDP), an orally administered purine derivative known as hypoxanthine riboside, exhibits antihypoxic and antihyperthermic effects. Furthermore, it demonstrates antiarrhythmic properties in cats, rabbits, and mice suffering from Ouabain-induced cardiac rhythm abnormalities. Additionally, Riboxin offers protection to animals from the harmful consequences of γ-irradiation [1] [2].
    • Inquiry Price
    8-10 weeks
    Size
    QTY
  • VK-II-86
    T8965955371-84-3
    VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity
    • $127
    35 days
    Size
    QTY
  • Cinobufagin (Standard)
    TMSM-1899470-37-1
    Cinobufagin (Standard) is a reference standard for research and analysis in studies involving Cinobufagin. Cinobufagin (Cinobufagine) is a selective Na+/K+-ATPase inhibitor. The activity of Cinobufagin is same as ouabain.
    • $275
    7-10 days
    Size
    QTY